452 filings
Page 17 of 23
6-K
CLLS
Cellectis
1 Sep 17
Current report (foreign)
12:00am
6-K
CLLS
Cellectis
17 Aug 17
Cellectis S.a. 6-K
12:00am
6-K
CLLS
Cellectis
2 Aug 17
Current report (foreign)
12:00am
6-K
CLLS
Cellectis
2 Aug 17
Cellectis Reports Financial Results for 2nd Quarter and First Six Months 2017
12:00am
6-K
CLLS
Cellectis
25 Jul 17
Calyxt Announces Full Exercise of Over-Allotment Option and Closing of its Initial Public Offering
12:00am
6-K
CLLS
Cellectis
25 Jul 17
Cellectis S.a. 6-K
12:00am
6-K
CLLS
Cellectis
24 Jul 17
Cellectis Granted Patent for CRISPR Use in T-Cells
12:00am
3
CBUS
Cibus Inc - Ordinary Shares
20 Jul 17
Initial statement of insider ownership
12:00am
6-K
CLLS
Cellectis
20 Jul 17
Cellectis S.a. 6-K
12:00am
6-K
CLLS
Cellectis
11 Jul 17
Cellectis S.a. 6-K
12:00am
6-K
CLLS
Cellectis
28 Jun 17
Cellectis Appoints Rainer Boehm, M.D. and Hervé Hoppenot to Board of Directors
12:00am
6-K
CLLS
Cellectis
27 Jun 17
Cellectis S.a. 6-K
12:00am
6-K
CLLS
Cellectis
26 Jun 17
Resolutions Within the Competence of the Ordinary Shareholders’ Meeting
12:00am
6-K
CLLS
Cellectis
26 Jun 17
Cellectis S.a. 6-K
12:00am
6-K
CLLS
Cellectis
23 Jun 17
Calyxt Files Registration Statement for Proposed Initial Public Offering
12:00am
6-K
CLLS
Cellectis
9 Jun 17
Cellectis S.a. 6-K
12:00am
6-K
CLLS
Cellectis
7 Jun 17
Calyxt Names Joseph B. Saluri as General Counsel & EVP, Corporate Development
12:00am
6-K
CLLS
Cellectis
16 May 17
Calyxt Launches U.S. Field Trials with University of Minnesota for Powdery Mildew-Resistant Spring Wheat Variety
12:00am
6-K
CLLS
Cellectis
10 May 17
Cellectis Patent Encompassing Broad Uses of Gene Editing Technologies Maintained by USPTO
12:00am
6-K
CLLS
Cellectis
10 May 17
Calyxt Patent Encompassing Broad Uses of Plant Gene Editing Technologies Maintained by USPTO
12:00am